Has Eastman Chemical (EMN) Fallen Far Enough To Look Undervalued?

Eastman Chemical (EMN) stock has declined 21.8% over five years, prompting valuation analysis. A DCF model suggests shares are undervalued by 42.5%, while earnings multiples indicate fair pricing at a P/E of 20.3x.